[
    [
        {
            "time": "2021-12-01",
            "original_text": "Why Moderna and Pfizer Beat the Market Today",
            "features": {
                "keywords": [
                    "Moderna",
                    "Pfizer",
                    "Market",
                    "Beat"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 8,
                "Duration": 3,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 10,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-12-02",
            "original_text": "CDC Advisors Recommend Pfizer and Moderna’s Vaccines Over J&J’s",
            "features": {
                "keywords": [
                    "CDC",
                    "Advisors",
                    "Recommend",
                    "Pfizer",
                    "Moderna",
                    "Vaccines",
                    "J&J"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-12-03",
            "original_text": "Doctor says 'We have to prepare for a surge' amid the Omicron variant's surge",
            "features": {
                "keywords": [
                    "Doctor",
                    "Prepare",
                    "Surge",
                    "Omicron",
                    "Variant"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-12-04",
            "original_text": "UPDATE 5-CDC recommends Moderna, Pfizer COVID-19 vaccines over J&J's",
            "features": {
                "keywords": [
                    "CDC",
                    "Recommends",
                    "Moderna",
                    "Pfizer",
                    "COVID-19",
                    "Vaccines",
                    "J&J"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-12-05",
            "original_text": "Omicron is 'very transmissible,' doctor explains, and ‘people need to stay vigilant’",
            "features": {
                "keywords": [
                    "Omicron",
                    "Transmissible",
                    "Doctor",
                    "Vigilant"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-12-06",
            "original_text": "10 Biotech Stocks in Billionaire Ray Dalio’s Portfolio",
            "features": {
                "keywords": [
                    "Biotech",
                    "Stocks",
                    "Billionaire",
                    "Ray Dalio",
                    "Portfolio"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "biotech"
                ],
                "causal_factor": "false",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-12-07",
            "original_text": "Unstoppable Dividend King for 2022: AbbVie or Johnson & Johnson?",
            "features": {
                "keywords": [
                    "Dividend",
                    "King",
                    "AbbVie",
                    "Johnson & Johnson"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-12-08",
            "original_text": "UPDATE 1-EU watchdog okays production capacity hikes for J&J, Moderna, Pfizer vaccines",
            "features": {
                "keywords": [
                    "EU",
                    "Watchdog",
                    "Production",
                    "Capacity",
                    "Hikes",
                    "J&J",
                    "Moderna",
                    "Pfizer",
                    "Vaccines"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-12-09",
            "original_text": "Airline CEOs clash with lawmakers over travel recovery, pilot shortage",
            "features": {
                "keywords": [
                    "Airline",
                    "CEOs",
                    "Lawmakers",
                    "Travel",
                    "Recovery",
                    "Pilot",
                    "Shortage"
                ],
                "sentiment_score": -0.4,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "transportation",
                    "aviation"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 5,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-12-10",
            "original_text": "J&J's (JNJ) COVID-19 Booster Jab Gets CHMP Recommendation",
            "features": {
                "keywords": [
                    "J&J",
                    "COVID-19",
                    "Booster",
                    "CHMP",
                    "Recommendation"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-12-11",
            "original_text": "Teva Pharmaceutical Finance Netherlands IV BV -- Moody's affirms Teva's Ba2 ratings; outlook revised to stable",
            "features": {
                "keywords": [
                    "Teva",
                    "Pharmaceutical",
                    "Moody's",
                    "Ba2",
                    "Ratings",
                    "Stable"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 3,
                "Entity_Density": 7,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-12-12",
            "original_text": "10 Dividend Stocks with over 11% Yield",
            "features": {
                "keywords": [
                    "Dividend",
                    "Stocks",
                    "Yield"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "diversified"
                ],
                "causal_factor": "false",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 4,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-12-13",
            "original_text": "Coronavirus tally: Global cases of COVID-19 top 272 million and France restricts travel from UK over omicron variant",
            "features": {
                "keywords": [
                    "Coronavirus",
                    "Global",
                    "Cases",
                    "France",
                    "Restricts",
                    "Travel",
                    "Omicron"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "global health"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-12-14",
            "original_text": "Russell Investment Funds Buys Catalent Inc, Willis Towers Watson PLC, Edison International, ...",
            "features": {
                "keywords": [
                    "Russell",
                    "Investment",
                    "Funds",
                    "Buys",
                    "Catalent",
                    "Willis",
                    "Towers",
                    "Watson",
                    "Edison",
                    "International"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "diversified"
                ],
                "causal_factor": "false",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-12-15",
            "original_text": "UPDATE 1-U.S. CDC advisers to weigh limits on J&J vaccine due to blood clot issues -Washington Post",
            "features": {
                "keywords": [
                    "CDC",
                    "Advisers",
                    "Limits",
                    "J&J",
                    "Vaccine",
                    "Blood",
                    "Clot",
                    "Issues"
                ],
                "sentiment_score": -0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]